ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

10,800Medicare Part D Prescriptions Filled, Including Refills
$438K Total Retail Price of All Prescriptions
321 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 603 574
WARFARIN SODIUM 578 512
LISINOPRIL 456 440
LEVOTHYROXINE SODIUM 366 333
SIMVASTATIN 361 352
METOPROLOL SUCCINATE 301 298
AMLODIPINE BESYLATE 276 276
ATENOLOL 268 258
ZOLPIDEM TARTRATE 265 247
ATORVASTATIN CALCIUM 240 240
LOSARTAN POTASSIUM 223 223
METOPROLOL TARTRATE 218 208
NIFEDIPINE ER 208 208
DIGOXIN 208 208
FUROSEMIDE 188 175
HYDROCHLOROTHIAZIDE 186 186
DIOVAN 183 183
METFORMIN HCL 171 154
CRESTOR 154 154
TRAZODONE HCL 153 127
CARVEDILOL 137 137
CITALOPRAM HBR 135 127
ALLOPURINOL 126 126
POTASSIUM CHLORIDE 120 108
PANTOPRAZOLE SODIUM 118 118
SERTRALINE HCL 117 117
ISOSORBIDE MONONITRATE ER 116 113
ENALAPRIL MALEATE 113 113
TAMSULOSIN HCL 104 104
PRAVASTATIN SODIUM 101 89
NITROSTAT 94 94
ALENDRONATE SODIUM 91 91
NAMENDA 89 89
POLYETHYLENE GLYCOL 3350 84 82
QUETIAPINE FUMARATE 72 65
SPIRONOLACTONE 70 70
PAROXETINE HCL 63 61
NEXIUM 63 63
GABAPENTIN 63 43
MIRTAZAPINE 60 50
CLONIDINE HCL 59 59
DONEPEZIL HCL 58 58
MECLIZINE HCL 53 42
GLIPIZIDE 52 52
LIDODERM 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.